ITRM

Iterum Therapeutics plc Ordinary Share

$0.03 -57.39%

Recent alerts on ITRM

All signals →

News ITRM Reports Results

SEC filing ITRM Faces Nasdaq Delisting, Fails $1 Bid Price, Risks Bankruptcy, Wind-Down

SEC filing ITRM Rejects Share Capital Increase, Directors' Allotment Authority, Pre-Emption Opt-Out, Reverse Split; Warns Going-Concern Doubt, Capital Raise Limits, Asset Sale or Bankruptcy Loom

News Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025

Get push alerts for ITRM

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS